NPM1 and acute myeloid leukemia: Per ELN, NPM1 mutated AML with FLT3-ITD AR <0.5 is considered as a favorable prognostic subgroup, similar to AML with absent FLT3-ITD mutation, and stem cell transplant is not recommended (34).